Characterization of circulating APOL1 protein complexes in African Americans

J Lipid Res. 2016 Jan;57(1):120-30. doi: 10.1194/jlr.M063453. Epub 2015 Nov 18.

Abstract

APOL1 gene renal-risk variants are associated with nephropathy and CVD in African Americans; however, little is known about the circulating APOL1 variant proteins which reportedly bind to HDL. We examined whether APOL1 G1 and G2 renal-risk variant serum concentrations or lipoprotein distributions differed from nonrisk G0 APOL1 in African Americans without nephropathy. Serum APOL1 protein concentrations were similar regardless of APOL1 genotype. In addition, serum APOL1 protein was bound to protein complexes in two nonoverlapping peaks, herein referred to as APOL1 complex A (12.2 nm diameter) and complex B (20.0 nm diameter). Neither of these protein complexes associated with HDL or LDL. Proteomic analysis revealed that complex A was composed of APOA1, haptoglobin-related protein (HPR), and complement C3, whereas complex B contained APOA1, HPR, IgM, and fibronectin. Serum HPR was less abundant on complex B in individuals with G1 and G2 renal-risk variant genotypes, relative to G0 (P = 0.0002-0.037). These circulating complexes may play roles in HDL metabolism and susceptibility to CVD.

Keywords: apolipoprotein L1; apolipoproteins; high density lipoprotein; kidney; proteomics; renal disease.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Apolipoprotein L1
  • Apolipoproteins / blood*
  • Apolipoproteins / genetics
  • Black or African American*
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / genetics
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Humans
  • Kidney Diseases / blood
  • Kidney Diseases / genetics
  • Lipoproteins, HDL / blood*
  • Lipoproteins, HDL / genetics
  • Male
  • Middle Aged
  • Proteomics
  • Risk Factors

Substances

  • APOL1 protein, human
  • Apolipoprotein L1
  • Apolipoproteins
  • Lipoproteins, HDL